COVID-19 tests and international travel: How long will you test positive for SAR-CoV-2

IF 0.2 Q4 RESPIRATORY SYSTEM Current Respiratory Medicine Reviews Pub Date : 2022-09-20 DOI:10.2174/1573398x18666220920120531
K. Hon, K. Leung
{"title":"COVID-19 tests and international travel: How long will you test positive for SAR-CoV-2","authors":"K. Hon, K. Leung","doi":"10.2174/1573398x18666220920120531","DOIUrl":null,"url":null,"abstract":"\n\nCoronavirus diseases, from SARS, to MERS and now COVID-19 have major implications on the aviation industry and international travels. Although many cities and countries are adopting ‘live with COVID’ strategies, various rules and regulations are still in place. Documents demonstrating COVID-19 vaccination or recovery from the disease have now become a basic requirement to enter many travel destinations, while some of which still require pre-entry and/or post-arrival testing of COVID-19. Recently, the author’s household became COVID-19 positive in late March 2022 by rapid antigen test (RAT) in Singapore whilst enroute to Hong Kong. This had an immediate knock-on impact on hotel quarantine and travel arrangements. Rapid antigen test (RAT) and Polymerase Chain Reaction (PCR) based tests have been used for quarantine, isolation and international travel purposes. The implications and issues of these tests are discussed. Ideally, a COVID-19 test that is fit for purpose should aim at identifying individuals who are infectious with risk of transmission only. Frequent surveillance with an effective RAT may be a more practical solution to normalize international travel without compromising public safety. Meanwhile, physicians have an important role in counselling anxious and often confused travelers before and during international travels. International travelers should be aware of the implications of these COVID-19 testing results; and plan, schedule and have travel insurance accordingly.\n","PeriodicalId":44030,"journal":{"name":"Current Respiratory Medicine Reviews","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Respiratory Medicine Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573398x18666220920120531","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Coronavirus diseases, from SARS, to MERS and now COVID-19 have major implications on the aviation industry and international travels. Although many cities and countries are adopting ‘live with COVID’ strategies, various rules and regulations are still in place. Documents demonstrating COVID-19 vaccination or recovery from the disease have now become a basic requirement to enter many travel destinations, while some of which still require pre-entry and/or post-arrival testing of COVID-19. Recently, the author’s household became COVID-19 positive in late March 2022 by rapid antigen test (RAT) in Singapore whilst enroute to Hong Kong. This had an immediate knock-on impact on hotel quarantine and travel arrangements. Rapid antigen test (RAT) and Polymerase Chain Reaction (PCR) based tests have been used for quarantine, isolation and international travel purposes. The implications and issues of these tests are discussed. Ideally, a COVID-19 test that is fit for purpose should aim at identifying individuals who are infectious with risk of transmission only. Frequent surveillance with an effective RAT may be a more practical solution to normalize international travel without compromising public safety. Meanwhile, physicians have an important role in counselling anxious and often confused travelers before and during international travels. International travelers should be aware of the implications of these COVID-19 testing results; and plan, schedule and have travel insurance accordingly.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19检测和国际旅行:你的新冠病毒检测呈阳性会持续多久
从SARS到MERS,再到现在的新冠肺炎,冠状病毒疾病对航空业和国际旅行都有重大影响。尽管许多城市和国家正在采取“与新冠肺炎共存”的策略,但各种规则和条例仍然存在。证明新冠肺炎疫苗接种或疾病康复的文件现在已成为进入许多旅行目的地的基本要求,而其中一些目的地仍需要新冠肺炎入境前和/或抵达后检测。最近,提交人的家人在前往香港的途中,于2022年3月下旬在新加坡通过快速抗原检测(RAT)呈新冠肺炎阳性。这对酒店隔离和旅行安排产生了直接的连锁反应。基于快速抗原检测(RAT)和聚合酶链式反应(PCR)的检测已被用于检疫、隔离和国际旅行目的。讨论了这些测试的含义和问题。理想情况下,适合目的的新冠肺炎检测应旨在识别仅具有传播风险的传染性个体。使用有效RAT进行频繁监控可能是一种更实用的解决方案,可以在不损害公共安全的情况下使国际旅行正常化。与此同时,医生在国际旅行之前和期间为焦虑且经常感到困惑的旅行者提供咨询方面发挥着重要作用。国际旅行者应该意识到这些新冠肺炎检测结果的影响;并相应地计划、安排和购买旅行保险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
53
期刊介绍: Current Respiratory Medicine Reviews publishes frontier reviews on all the latest advances on respiratory diseases and its related areas e.g. pharmacology, pathogenesis, clinical care, and therapy. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in respiratory medicine.
期刊最新文献
Assessing Lung Function and Quality of Life in COVID-19 Patients: A Pilot Study Pulmonary Arterial Hypertension (PAH) Group 1 (Part A): Overview, Classification, Clinical Subsets, and Workup Deteriorating Pulmonary Functions in Patients with Rheumatoid Arthritis- A Pilot Study From South India COVID-19 Vaccines and the Menstrual Cycle: A Cross-Sectional Study NAT2 Gene Variants as a Provocative Factor for the Severe Course of COVID-19 Pneumonia in Ukrainian Patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1